How do you feel the oral IL-23 (Icotyde) will shape psoriasis management?

I think this new med will be the leading first-line systemic medication for psoriasis patients who have been inadequately controlled by topicals but are hesitant to go straight to a biologic. Systemic treatment-naive psoriasis patients will likely represent the largest population of new oral IL-23 s...